Literature DB >> 12969166

Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients.

Haimanot Wasse1, Daniel L Gillen, Adrianne M Ball, Bryan R Kestenbaum, Stephen L Seliger, Donald Sherrard, Catherine O Stehman-Breen.   

Abstract

BACKGROUND: The risk of upper gastrointestinal bleeding (UGIB) is increased among end-stage renal disease (ESRD) patients compared to the general population. However, correlates of UGIB among ESRD patients remain unknown. We conducted a cohort study of dialysis patients to ascertain risk factors for UGIB.
METHODS: Data from the United States Renal Data System Dialysis Morbidity and Mortality Studies, Waves 2-4 were used to identify risk factors for incident UGIB among ESRD patients. First hospitalizations for UGIB were identified using hospital diagnosis codes between 12/31/93 and 12/31/99. Cox regression was used to estimate the association between predictors of interest and first diagnosis of UGIB.
RESULTS: Cases of UGIB (698) were observed over 30648 patient years of follow-up. Before adjustment for confounding factors, increasing age, diabetes, former and current smoking, cardiovascular disease (CVD), lower serum albumin, malnutrition, and inability to ambulate independently were associated with an increased risk of UGIB, while African Americans and transplant patients had a lower risk of UGIB. After adjustment, African American race was associated with a lower risk of UGIB (RR = 0.90; 0.82, 0.98), while current smoking (RR = 1.11; confidence interval 1.03, 1.19), history of CVD (RR = 1.32; 1.10, 1.59), and inability to ambulate independently (RR = 1.32; 1.07, 1.63) were associated with a higher risk of UGIB. Age, gender, diabetes, lower serum albumin, nourishment, treatment modality, aspirin use, nonsteroidal anti-inflammatory drug (NSAID) use, and antiplatelet or anticoagulant medication use were not found to be significantly related to the risk of UGIB after adjustment for potential confounding factors.
CONCLUSION: CVD, current smoking, and risk factors suggesting more disability are associated with a greater risk of UGIB among patients with ESRD.

Entities:  

Mesh:

Year:  2003        PMID: 12969166     DOI: 10.1046/j.1523-1755.2003.00225.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  46 in total

Review 1.  Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review.

Authors:  Sara El Ouali; Alan Barkun; Myriam Martel; Davide Maggio
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

2.  Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Authors:  Wolfgang C Winkelmayer; Jun Liu; Soko Setoguchi; Niteesh K Choudhry
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

3.  Chronic kidney disease and end-stage renal disease predict higher risk of mortality in patients with primary upper gastrointestinal bleeding.

Authors:  Puneet Sood; Gagan Kumar; Rahul Nanchal; Ankit Sakhuja; Shahryar Ahmad; Muhammad Ali; Nilay Kumar; Edward A Ross
Journal:  Am J Nephrol       Date:  2012-02-04       Impact factor: 3.754

4.  Diagnostic utility of immunochemical fecal occult blood tests to detect lower gastrointestinal lesions in patients with chronic kidney disease.

Authors:  Yoo A Choi; Sang Hoon Yoo; Youn Mi Song; Se Young Kim; Yunju Nam; Sooa Choi; Bong Han Kong; Hye Eun Yoon; Yu Ah Hong; Yoon Kyung Chang; Chul Woo Yang; Suk Young Kim; Hyeon Seok Hwang
Journal:  Int J Colorectal Dis       Date:  2015-04-14       Impact factor: 2.571

Review 5.  Use of proton pump inhibitors in dialysis patients: a double-edged sword?

Authors:  Geoffroy Desbuissons; Lucile Mercadal
Journal:  J Nephrol       Date:  2020-07-24       Impact factor: 3.902

6.  Impact of discontinuing non-steroidal antiinflammatory drugs on long-term recurrence in colonic diverticular bleeding.

Authors:  Naoyoshi Nagata; Ryota Niikura; Tomonori Aoki; Takuro Shimbo; Katsunori Sekine; Hidetaka Okubo; Kazuhiro Watanabe; Toshiyuki Sakurai; Chizu Yokoi; Junichi Akiyama; Mikio Yanase; Masashi Mizokami; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

7.  Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients.

Authors:  Ju-Yeh Yang; Tsung-Chun Lee; Maria E Montez-Rath; Jane Paik; Glenn M Chertow; Manisha Desai; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

8.  Upper Gastrointestinal Bleeding in Patients with End Stage Renal Disease: Causes, Characteristics and Factors Associated with Need for Endoscopic Therapeutic Intervention.

Authors:  Syed Mudassir Laeeq; Abbas Ali Tasneem; Farina M Hanif; Nasir Hassan Luck; Rajesh Mandhwani; Rajesh Wadhva
Journal:  J Transl Int Med       Date:  2017-06-30

Review 9.  Oral anticoagulant therapy in hemodialysis patients: do the benefits outweigh the risks?

Authors:  Guido Finazzi; Giulio Mingardi
Journal:  Intern Emerg Med       Date:  2009-07-16       Impact factor: 3.397

Review 10.  Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates.

Authors:  Swapnil Hiremath; Rachel M Holden; Dean Fergusson; Deborah L Zimmerman
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.